Foreword
From Insight to Impact
Advancing clinical trials through RWE in Asia-Pacific
AsiaPacific is shaping a new era in clinical development As healthcare systems across the region confront rising
Strategy
Why Pharma Products still go to Waste — and How Better Logistics can Help
Every year pharmaceutical products worth billions of dollars are spent worldwide even as demand for lifesaving
Research & Development
Redefining Pharmaceutical Research and Training with Digital Twins and AI
Pharmaceutical education and training have traditionally focussed on inperson access to specialist equipment
From Monoliths to Ecosystems
The new R&D paradigm
Historically pharmaceutical innovation was concentrated among a small number of large companies
Manufacturing
Navigating the Future
The regulatory revolution in gene therapy
The cell and gene therapies CGTs landscape is evolving rapidly with transformative potential to potentially cure
Information Technology
Fine-tuning AI Models for Molecular Co-folding
Advancing drug discovery through data collaboration
Cofolding models predict how two or more interacting partners such as a protein and a ligand two proteins or a protein
Assessing the Merits of Agentic AI
What is it — and what is it for?
As the global life sciences industry embraces the latest advances in science and adapts to evolving regulatory demands
Expert Corner
Next-generation Water Systems in Pharma
Achieving operational excellence with process analytical technology
Since its introduction by the FDA in PAT has shifted quality assurance from endproduct testing to realtime
Breaking Barriers in bioanalytical automation
Challenges, milestones, and future pathways
Over the past two decades the most transformative milestones in bioanalytical automation have redefined how quality
FROM REAL WORLD TO REAL IMPACT
Transforming Trials in the Era of RWE in Asia-Pacific
APAC houses almost per cent of the worlds population However less than per cent of global trials are conducted
Advertorials
TRADITIONAL PHARMA FACILITIES
Time to rethink
In several recent cases companies have invested hundreds of millions of dollars in new plants only to face delayed integration
BioPharma
Microbiological QC Bottlenecks in Biopharma
How point-of-need biotechnologies are redefining the path forward
Microbial contamination remains a persistent challenge in biopharmaceutical manufacturing with risks arising
Rethinking Biotech Valuation
Why traditional models fail and how evidence-driven frameworks are reshaping R&D value
Biotech valuation is often framed as a precise discounted cash flow number Drug development behaves differently
